Related Experiment Video
Updated: Apr 21, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
Herpes zoster is associated with prior statin use: a population-based case-control study
Shiu-Dong Chung1, Ming-Chieh Tsai2, Shih-Ping Liu3
1Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan; Sleep Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
Prior statin use was linked to a higher occurrence of herpes zoster (HZ). This population-based study found statin users had an increased odds ratio for developing HZ.
Area of Science:
- Medical research
- Epidemiology
- Pharmacology
Background:
- Investigating the potential link between statin medication and herpes zoster (HZ) incidence.
- Utilizing a population-based case-control design for robust analysis.
Purpose of the Study:
- To determine if there is an association between prior statin use and the occurrence of herpes zoster (HZ).
Main Methods:
- A case-control study design was employed using data from the Taiwan Longitudinal Health Insurance Database 2000.
- Included 47,359 cases of HZ and 142,077 controls.
- Conditional logistic regression analysis was used to calculate odds ratios (OR) for statin use.
Main Results:
- 13.0% of subjects reported statin use, with higher prevalence in HZ cases (15.5%) versus controls (12.1%).
- Statin users showed an adjusted OR of 1.28 (95% CI: 1.24–1.32) for HZ.
- The highest OR for prior statin use among HZ cases was observed in the 18–44 age group (OR: 1.69; 95% CI: 1.45–1.92).
- Regular and irregular statin users had adjusted ORs of 1.32 (95% CI: 1.27–1.38) and 1.23 (95% CI: 1.18–1.29), respectively.
Conclusions:
- Prior statin use is significantly associated with an increased occurrence of herpes zoster (HZ).
- The findings suggest a potential link warranting further investigation into the mechanisms involved.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Viral Hepatitis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
